Looking for new antibiotic families.
Researchers used explainable deep learning to identify a structural class of antibiotic candidates.
- Maturity
- Experimental, stage 1 of 4
- Support
- 1 source · paper
- Evidence detail
- How we know ↓
Drug resistance creates demand for new classes of antibiotics.
Laboratory screening cannot easily cover huge chemical libraries.
Models predicted activity and highlighted chemical substructures.
What was shown, and what wasn’t
Shown
Candidate compounds showed antibacterial activity, including tests in mouse models.
Not shown · limits
- Preclinical findings do not demonstrate human safety or effectiveness.
Bright editorial interpretation
The results offer starting points for drug development.
Still open
Optimize candidates and establish safety.
How we know1 source · checked 2026-09-05 · no corrections
Original sources
Institutions: MIT & collaborators
- Maturity
- Experimental
- Source published
- 2023-12-20
- Last source review
- 2026-09-05
- Editorial method
- Original source check
- Place / relevance
- Cambridge, United States · institution-location
Bright compared this account with the linked original and supporting sources and kept reported, budgeted, projected, and observed claims distinct. Bright did not independently audit the underlying records.
Maturity describes the tested or operational setting. Confidence describes support for the particular claim; one does not determine the other.
Revision & correction history
No corrections recorded.
Keep exploring
Explore the shared question in another setting. These connections do not imply replication.